Survival in Patients with Neuroendocrine Tumours of the Small Intestine: Nomogram Validation and Predictors of Survival

التفاصيل البيبلوغرافية
العنوان: Survival in Patients with Neuroendocrine Tumours of the Small Intestine: Nomogram Validation and Predictors of Survival
المؤلفون: Sonja Levy, M. R. Vriens, Margot E T Tesselaar, Linde M. van Veenendaal, Gerlof D. Valk, Koert F. D. Kuhlmann, Wieke H M Verbeek, José G van den Berg, Catharina M. Korse, Emilie C H Breekveldt
المصدر: Journal of Clinical Medicine
Volume 9
Issue 8
Journal of Clinical Medicine, Vol 9, Iss 2502, p 2502 (2020)
بيانات النشر: Multidisciplinary Digital Publishing Institute, 2020.
سنة النشر: 2020
مصطلحات موضوعية: Oncology, medicine.medical_specialty, lcsh:Medicine, Liver tests, Article, Disease course, Unmet needs, nomogram, 03 medical and health sciences, 0302 clinical medicine, Neuroendocrine tumours, Internal medicine, medicine, In patient, 030304 developmental biology, 0303 health sciences, business.industry, lcsh:R, General Medicine, Nomogram, Small intestine, small-intestine, prediction model, medicine.anatomical_structure, 030220 oncology & carcinogenesis, Treatment strategy, prognosis, business
الوصف: Neuroendocrine tumours of the small intestine (SI-NETs) are rare and heterogeneous. There is an unmet need for prognostication of disease course and to aid treatment strategies. A previously developed nomogram based on clinical and tumour characteristics aims to predict disease-specific survival (DSS) in patients with a SI-NET. We aimed to validate the nomogram and identify predictors of survival. Four hundred patients with a grade 1 or 2 SI-NET were included, between January 2000 and June 2016. Predicted 5- and 10-year survival was compared to actual DSS. Multivariable analysis identified predictors for actual DSS. We found that in low-, medium- and high-risk groups 5-year nomogram DSS vs. actual DSS was 0.86 vs. 0.82 (p <
0.001), 0.52 vs. 0.71 (p <
0.001) and 0.26 vs. 0.53 (p <
0.001), respectively. Ten-year nomogram DSS vs. actual DSS was 0.68 vs. 0.69 (p <
0.001), 0.40 vs. 0.50 (p <
0.001) and 0.20 vs. 0.35 (p <
0.001), respectively. Age, WHO-performance score of 2, Ki-67 index &ge
10, unknown primary tumour, CgA >
6x ULN and elevated liver tests were identified as independent predictors for a worse DSS. This shows that the nomogram was able to differentiate, but underestimated DSS for patients with a SI-NET. Improvement of prognostication incorporating new emerging biomarkers is necessary to adequately estimate survival.
وصف الملف: application/pdf
اللغة: English
تدمد: 2077-0383
DOI: 10.3390/jcm9082502
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e1eff302be0c3883fb14667d4699b536Test
حقوق: OPEN
رقم الانضمام: edsair.doi.dedup.....e1eff302be0c3883fb14667d4699b536
قاعدة البيانات: OpenAIRE
الوصف
تدمد:20770383
DOI:10.3390/jcm9082502